Novavax
NVAX
#5101
Rank
C$2.58 B
Marketcap
C$15.65
Share price
-1.87%
Change (1 day)
25.43%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -C$0.32 Billion

According to Novavax's latest financial reports the company's current earnings are C$0.41 Billion. In 2025 the company made an earning of C$0.66 Billion, an increase over its 2024 earnings that were of -C$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.32 Billion-147.37%
2025 C$0.66 B-396.87%
2024 -C$0.23 Billion-70.39%
2023 -C$0.76 Billion-16.59%
2022 -C$0.91 Billion-62.58%
2021 -C$2.41 Billion320.54%
2020 -C$0.58 Billion234.22%
2019 -C$0.18 Billion-30.17%
2018 -C$0.25 Billion1.69%
2017 -C$0.25 Billion-36.44%
2016 -C$0.38 Billion70.4%
2015 -C$0.23 Billion89.27%
2014 -C$0.12 Billion59.83%
2013 -C$73.63 Million81.9%
2012 -C$40.48 Million50.33%
2011 -C$26.93 Million
2009 -C$53.14 Million8.8%
2008 -C$48.84 Million18.01%
2007 -C$41.39 Million18.33%
2006 -C$34.98 Million168.31%
2005 -C$13.04 Million-62.51%
2004 -C$34.78 Million52.4%
2003 -C$22.82 Million-28.21%
2002 -C$31.79 Million
2000 -C$18.12 Million177%
1999 -C$6.54 Million-11.54%
1998 -C$7.4 Million10.64%
1997 -C$6.69 Million-9.62%
1996 -C$7.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.06 B-7,047.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$9.81 B-3,191.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.37 B-6,514.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$11.21 B-3,631.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-C$0.19 Billion-41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.47 Billion 45.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$0.21 B-167.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-C$11.51 Million-96.38%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-C$0.55 Billion 70.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-C$0.14 Billion-57.43%๐Ÿ‡บ๐Ÿ‡ธ USA